NEURONES (NRO.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:NRO - FR0004050250 - Common Stock
42.45 EUR
-0.05 (-0.12%)
Overall NRO gets a fundamental rating of 6 out of 10. We evaluated NRO against 72 industry peers in the IT Services industry. NRO gets an excellent profitability rating and is at the same time showing great financial health properties. NRO is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
NRO had positive earnings in the past year.
In the past year NRO had a positive cash flow from operations.
NRO had positive earnings in each of the past 5 years.
Each year in the past 5 years NRO had a positive operating cash flow.
1.2 Ratios
NRO has a better Return On Assets (7.07%) than 79.17% of its industry peers.
NRO's Return On Equity of 13.67% is fine compared to the rest of the industry. NRO outperforms 63.89% of its industry peers.
NRO's Return On Invested Capital of 11.36% is fine compared to the rest of the industry. NRO outperforms 79.17% of its industry peers.
NRO had an Average Return On Invested Capital over the past 3 years of 12.21%. This is in line with the industry average of 11.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.07% | ||
| ROE | 13.67% | ||
| ROIC | 11.36% |
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
1.3 Margins
NRO has a better Profit Margin (6.10%) than 70.83% of its industry peers.
In the last couple of years the Profit Margin of NRO has remained more or less at the same level.
The Operating Margin of NRO (8.88%) is better than 69.44% of its industry peers.
In the last couple of years the Operating Margin of NRO has remained more or less at the same level.
NRO has a Gross Margin of 99.93%. This is amongst the best in the industry. NRO outperforms 95.83% of its industry peers.
NRO's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.88% | ||
| PM (TTM) | 6.1% | ||
| GM | 99.93% |
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NRO is still creating some value.
Compared to 1 year ago, NRO has about the same amount of shares outstanding.
The number of shares outstanding for NRO remains at a similar level compared to 5 years ago.
Compared to 1 year ago, NRO has an improved debt to assets ratio.
2.2 Solvency
NRO has an Altman-Z score of 4.51. This indicates that NRO is financially healthy and has little risk of bankruptcy at the moment.
NRO has a better Altman-Z score (4.51) than 91.67% of its industry peers.
NRO has a debt to FCF ratio of 0.57. This is a very positive value and a sign of high solvency as it would only need 0.57 years to pay back of all of its debts.
NRO has a Debt to FCF ratio of 0.57. This is amongst the best in the industry. NRO outperforms 94.44% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that NRO is not too dependend on debt financing.
NRO's Debt to Equity ratio of 0.08 is amongst the best of the industry. NRO outperforms 90.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 4.51 |
ROIC/WACC1.43
WACC7.97%
2.3 Liquidity
NRO has a Current Ratio of 2.31. This indicates that NRO is financially healthy and has no problem in meeting its short term obligations.
NRO's Current ratio of 2.31 is amongst the best of the industry. NRO outperforms 94.44% of its industry peers.
NRO has a Quick Ratio of 2.31. This indicates that NRO is financially healthy and has no problem in meeting its short term obligations.
NRO's Quick ratio of 2.31 is amongst the best of the industry. NRO outperforms 95.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 |
3. Growth
3.1 Past
NRO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.56%.
The Earnings Per Share has been growing by 11.23% on average over the past years. This is quite good.
NRO shows a small growth in Revenue. In the last year, the Revenue has grown by 7.39%.
The Revenue has been growing by 9.70% on average over the past years. This is quite good.
EPS 1Y (TTM)4.56%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
3.2 Future
Based on estimates for the next years, NRO will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.04% on average per year.
NRO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.57% yearly.
EPS Next Y-4.76%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue Next Year6.24%
Revenue Next 2Y5.88%
Revenue Next 3Y5.93%
Revenue Next 5Y5.57%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.41, NRO is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as NRO.
The average S&P500 Price/Earnings ratio is at 25.45. NRO is around the same levels.
Based on the Price/Forward Earnings ratio of 18.27, the valuation of NRO can be described as rather expensive.
NRO's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of NRO to the average of the S&P500 Index (34.46), we can say NRO is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.41 | ||
| Fwd PE | 18.27 |
4.2 Price Multiples
69.44% of the companies in the same industry are more expensive than NRO, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as NRO.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.28 | ||
| EV/EBITDA | 5.96 |
4.3 Compensation for Growth
The decent profitability rating of NRO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.82
EPS Next 2Y4.65%
EPS Next 3Y8.74%
5. Dividend
5.1 Amount
NRO has a Yearly Dividend Yield of 3.07%.
NRO's Dividend Yield is a higher than the industry average which is at 3.84.
NRO's Dividend Yield is a higher than the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.07% |
5.2 History
The dividend of NRO is nicely growing with an annual growth rate of 82.05%!
Dividend Growth(5Y)82.05%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
NRO pays out 57.40% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of NRO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.4%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPA:NRO (11/21/2025, 7:00:00 PM)
42.45
-0.05 (-0.12%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners13.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.03B
Revenue(TTM)832.18M
Net Income(TTM)50.74M
Analysts84
Price Target53.04 (24.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.07% |
Yearly Dividend1.2
Dividend Growth(5Y)82.05%
DP57.4%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.41 | ||
| Fwd PE | 18.27 | ||
| P/S | 1.24 | ||
| P/FCF | 14.28 | ||
| P/OCF | 12.24 | ||
| P/B | 2.78 | ||
| P/tB | 3.35 | ||
| EV/EBITDA | 5.96 |
EPS(TTM)2.08
EY4.9%
EPS(NY)2.32
Fwd EY5.47%
FCF(TTM)2.97
FCFY7%
OCF(TTM)3.47
OCFY8.17%
SpS34.2
BVpS15.26
TBVpS12.69
PEG (NY)N/A
PEG (5Y)1.82
Graham Number26.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.07% | ||
| ROE | 13.67% | ||
| ROCE | 15.75% | ||
| ROIC | 11.36% | ||
| ROICexc | 28.09% | ||
| ROICexgc | 41.87% | ||
| OM | 8.88% | ||
| PM (TTM) | 6.1% | ||
| GM | 99.93% | ||
| FCFM | 8.69% |
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.96%
ROCE(5y)16.06%
ROICexgc growth 3YN/A
ROICexgc growth 5Y9.54%
ROICexc growth 3YN/A
ROICexc growth 5Y6.91%
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
F-Score7
Asset Turnover1.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 68.18% | ||
| Cap/Sales | 1.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.17% | ||
| Profit Quality | 142.58% | ||
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 | ||
| Altman-Z | 4.51 |
F-Score7
WACC7.97%
ROIC/WACC1.43
Cap/Depr(3y)79.83%
Cap/Depr(5y)65.86%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.6%
Profit Quality(3y)115.8%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)4.56%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
EPS Next Y-4.76%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
Revenue Next Year6.24%
Revenue Next 2Y5.88%
Revenue Next 3Y5.93%
Revenue Next 5Y5.57%
EBIT growth 1Y0.45%
EBIT growth 3Y8.08%
EBIT growth 5Y9.67%
EBIT Next Year11.84%
EBIT Next 3Y14.14%
EBIT Next 5Y11.67%
FCF growth 1Y13.09%
FCF growth 3Y7.7%
FCF growth 5Y6.25%
OCF growth 1Y11.34%
OCF growth 3Y9.37%
OCF growth 5Y6.59%
NEURONES / NRO.PA FAQ
What is the fundamental rating for NRO stock?
ChartMill assigns a fundamental rating of 6 / 10 to NRO.PA.
Can you provide the valuation status for NEURONES?
ChartMill assigns a valuation rating of 3 / 10 to NEURONES (NRO.PA). This can be considered as Overvalued.
Can you provide the profitability details for NEURONES?
NEURONES (NRO.PA) has a profitability rating of 7 / 10.
What is the financial health of NEURONES (NRO.PA) stock?
The financial health rating of NEURONES (NRO.PA) is 9 / 10.
What is the expected EPS growth for NEURONES (NRO.PA) stock?
The Earnings per Share (EPS) of NEURONES (NRO.PA) is expected to decline by -4.76% in the next year.